-
CytoMed Therapeutics (GDTC) signs Business & Research Collaboration Agreement with India’s SunAct Cancer Institute Private Limited
-
CytoMed Therapeutics (GDTC) first-in-human Phase I ANGELICA clinical trial using its patented donor allogeneicCAR-T cell against blood and solid tumors received co-funding support from the NMRC Clinic
-
CytoMed Therapeutics (GDTC) Acquires Cord Blood Banking Licence and Assets

